Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Journal of clinical oncology official journal of the American Society of Clinical Oncology(2024)

Cited 0|Views1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined